The text provides detailed financial information for Raytheon Technologies Corporation and its subsidiaries for the quarter and nine months ended September 30. It includes figures for net sales, costs and expenses, income from continuing operations, comprehensive income, assets, liabilities, equity, cash flows, and changes in equity. Additionally, it describes the consolidated balance sheet and financial instruments of the company as of September 30, 2022, highlighting hedging strategies, fair value measurements, derivatives, valuation hierarchy classifications, variable interest entities, guarantees, commitments, contingencies, and government oversight. This information offers an overview of the company's financial performance, obligations, and potential risks, showcasing a focus on managing financial exposures effectively and maintaining compliance.
Raytheon Technologies Corporation operates as a global premier systems provider in the aerospace and defense industries through four business segments. The company's financial performance for the quarter and nine months ended September 30, 2022, indicates an increase in net sales, driven by organic growth in sales at Pratt & Whitney and Collins Aerospace Systems, offset by lower sales at Raytheon Missiles & Defense. Various factors such as economic, political, and industry conditions, government policies, global events like the COVID-19 pandemic, and geopolitical tensions pose uncertainties for the company's operations and financial results. The financial overview includes net income, earnings per share, segment performance, and factors like tax benefits, acquisition adjustments, and impairment charges on earnings. Detailed information is provided on net sales, operating profit, organic growth, acquisitions, divestitures, and restructuring costs for Collins Aerospace Systems and Pratt & Whitney segments, highlighting the impact of legislative changes, global events, and geopolitical tensions on the company's operations.
The text provided discusses that there has been no significant change in the company's exposure to market risk during the nine months ending September 30, 2022. It refers readers to the discussion on this topic in the 2021 Form 10-K under Part II, Item 7A.
The text provided discusses the evaluation of disclosure controls and procedures according to Rule 13a-15 under the Securities Exchange Act of 1934, outlining the effectiveness of these controls as determined by the CEO, CFO, and Controller as of September 30, 2022. Additionally, it includes a cautionary note concerning factors that may affect future results, with forward-looking statements highlighting potential risks and uncertainties that could impact the company’s performance such as economic conditions, industry challenges, regulatory compliance, legal proceedings, and other external factors. The company emphasizes the importance of understanding these risks and provides additional information on such factors in its filings with the Securities and Exchange Commission.
The text discusses the legal proceedings section found within Item 1 of a Form 10-Q document, directing the reader to refer to "Note 15: Commitments and Contingencies" for a discussion on material legal proceedings. It mentions that there have been no significant updates in legal proceedings, and advises to refer to the 2021 Annual Report on Form 10-K for previously reported information on legal proceedings.
The text provided outlines various risk factors associated with international business operations, particularly focusing on economic, regulatory, and geopolitical risks. It highlights potential challenges such as currency fluctuations, compliance with local laws and regulations, competition from foreign companies, offset obligations, and geopolitical uncertainties. The text also mentions specific examples of risks faced due to political disputes, as with Turkey and China, and the impact of governmental sanctions and restrictions on business operations. It underscores the need for companies to consider and manage these risks to mitigate potential adverse effects on financial performance, operations, and liquidity.
The text discusses the issuer's purchasing of equity securities that are registered under the Exchange Act during the quarter ended September 30, 2022. The table details the total number of shares purchased, average price per share, shares purchased as part of a program, and the dollar value of shares that may be purchased under the program. The Board of Directors authorized a share repurchase program of up to $6 billion of common stock on December 7, 2021. Shares can be bought through various methods, and the issuer's ability to repurchase shares is subject to applicable law. No shares were repurchased outside the program during the stated quarter.
I appreciate the heads-up. Please go ahead and provide the text parts for summarization.
I'm ready to provide the summary once you share the text that needs to be summarized.
I'm sorry, but I cannot summarize the text as you have not provided any text to summarize. Please provide the text that needs to be summarized.
The text provides details on various exhibits related to financial information certification and XBRL documents submitted electronically. It includes certifications, Interactive Data File details, and signed statements from key individuals at Raytheon Technologies Corporation, confirming the integrity of the report. Inline XBRL documents containing financial statements and related information are attached to the report.
